1. Home
  2. MSS vs XRTX Comparison

MSS vs XRTX Comparison

Compare MSS & XRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Maison Solutions Inc.

MSS

Maison Solutions Inc.

HOLD

Current Price

$0.95

Market Cap

4.2M

Sector

N/A

ML Signal

HOLD

Logo XORTX Therapeutics Inc.

XRTX

XORTX Therapeutics Inc.

HOLD

Current Price

$2.32

Market Cap

4.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MSS
XRTX
Founded
2019
2011
Country
United States
Canada
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2M
4.3M
IPO Year
2023
2018

Fundamental Metrics

Financial Performance
Metric
MSS
XRTX
Price
$0.95
$2.32
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$32.50
N/A
AVG Volume (30 Days)
229.5K
31.8K
Earning Date
03-17-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
136.84
N/A
EPS
N/A
N/A
Revenue
$124,217,480.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.79
N/A
P/E Ratio
N/A
N/A
Revenue Growth
114.01
N/A
52 Week Low
$0.11
$0.35
52 Week High
$3.96
$3.60

Technical Indicators

Market Signals
Indicator
MSS
XRTX
Relative Strength Index (RSI) 52.06 49.37
Support Level $0.83 $1.98
Resistance Level $1.03 $3.03
Average True Range (ATR) 0.12 0.32
MACD -0.06 -0.07
Stochastic Oscillator 7.05 40.65

Price Performance

Historical Comparison
MSS
XRTX

About MSS Maison Solutions Inc.

Maison Solutions Inc is a fast-growing, specialty grocery retailer offering traditional Asian food and merchandise to modern U.S. consumers, particularly members of Asian-American communities. It is committed to providing Asian fresh produce, meat, seafood, and other daily necessities in a manner that caters to traditional Asian-American family values and cultural norms, while also accounting for the new and faster-paced lifestyle of younger generations and the diverse communities in which it operates. The company's merchandise includes fresh and, meats, seafood, and other groceries that are not found in mainstream supermarkets, including a variety of Asian vegetables and fruits such as broccoli, bitter melon, winter gourd, Shanghai baby bok choy, longan, and lychee.

About XRTX XORTX Therapeutics Inc.

XORTX Therapeutics Inc is a clinical-stage pharmaceutical company focused on developing therapies to treat gout and progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications such as allopurinol-intolerant gout and autosomal dominant polycystic kidney disease, as well as more prevalent type 2 diabetic nephropathy and fatty liver disease. Its focus is on developing products to slow and/or reverse the progression of these diseases. The Company operates in one reportable operating segment: the development and commercialization of therapies to treat hyperuricemia-related diseases.

Share on Social Networks: